C Eric Winzer's Net Worth
$1.11 Million
Who is C Eric Winzer?
C Eric Winzer has an estimated net worth of $1.11 Million. This is based on reported shares across multiple companies, which include Nuo Therapeutics, Inc., AVALON PHARMACEUTICALS INC, and INVITROGEN CORP.
SEC CIK
C Eric Winzer's CIK is 0001205362
Past Insider Trading and Trends
2003 was C Eric Winzer's most active year for acquiring shares with 32 total transactions. C Eric Winzer's most active month to acquire stocks was the month of October. 2003 was C Eric Winzer's most active year for disposing of shares, totalling 52 transactions. C Eric Winzer's most active month to dispose stocks was the month of October. 2003 saw C Eric Winzer paying a total of $1,994,753.89 for 80,142 shares, this is the most they've acquired in one year. In 2003 C Eric Winzer cashed out on 100,000 shares for a total of $6,259,020.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuo Therapeutics, Inc. (AURX) Snapshot price: $0.7499
InvestorC Eric Winzer owns 25,000 units of Common Stock, par value $0.0001 per share which is worth $18,747.50. From 2019 to 2024 C Eric Winzer acquired a total of 25,000 shares in Nuo Therapeutics, Inc. at a cost of $25,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
∞
| 25K |
$1.00 | $25,000.00 | 25K |
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVALON PHARMACEUTICALS INC No price found
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INVITROGEN CORP No price found
CFOC Eric Winzer owns 2,706 units of Common Stock. In the year 2003 C Eric Winzer acquired a total of 50,726 shares in INVITROGEN CORP at a cost of $2,008,777.19, C also disposed a total of 50,000 shares of INVITROGEN CORP equalling to $3,129,510.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
| +27.52% | 584 |
$24.01 | $14,023.30 | 2.71K |
Jan 30 - Apr 30
| |||
Form 4
|
—
|
0
|
$49.45 | -$1,781.58 | 2.12K |
Nov 12
| |||
Form 4
|
—
|
0
|
$47.77 | -$415,784.31 | 2.12K |
Nov 12
| |||
Form 4
|
—
|
0
|
$56.02 | -$283,724.00 | 2.12K |
Nov 11
| |||
Form 4
| +2.22% | 46 |
$47.43 | -$435,771.42 | 2.12K |
Oct 31 - Nov 10
| |||
Form 4
| +4.85% | 96 |
$24.01 | $2,305.20 | 2.08K |
Jan 31 - Oct 15
| |||
| No matching records found | |||||||||